Stock · NSE
LUPIN
2,029.30▲ 18.30 (0.91%)Last 2 days · 15m candles9/10/2026, 02:53:30
Open: 2,010.90High: 2,031.00Low: 2,005.60Prev: 2,011.00
VERIFIEDMint Markets·17h★ ON YOUR LIST
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target priceAI summary· NEUTRAL
- ·Pharma exporters may benefit from rupee depreciation ahead of Q2 results.
- ·Elevated freight and input costs pose potential risks for the sector.
- ·InCred identifies potential pressure on Dr Reddy’s, Divi’s, Lupin, Cipla, Torrent Pharma, and Blue Jet Healthcare in Q2FY27.
VERIFIEDET Finance·2d★ ON YOUR LIST
Lupin launches fixed-dose triple combination inhaler for COPD in IndiaAI summary· NEUTRAL
- ·Lupin Ltd has launched Formoflo-G MDI, a fixed-dose triple combination inhaler for COPD management in India.
- ·The inhaler combines three therapies into a single device for improved treatment outcomes.
- ·The Drug Controller General of India has approved the product, which aims to benefit over 55 million people with COPD in India.
VERIFIEDET Markets·32d★ ON YOUR LIST
Stocks in news: Tata Motors, RVNL, Eicher Motors, Mazagon Dock and LupinAI summary· NEUTRAL
- ·Nifty 50 has extended its losing streak for four weeks.
- ·Tata Motors and Rail Vikas Nigam are expected to be active on Monday.
- ·Lupin received US FDA approval.
VERIFIEDET Stocks·32d★ ON YOUR LIST
Stocks in news: Tata Motors, RVNL, Eicher Motors, Mazagon Dock and LupinAI summary· NEUTRAL
- ·Nifty 50 has extended its losing streak for four weeks.
- ·Tata Motors and Rail Vikas Nigam are expected to be active on Monday.
- ·Lupin received US FDA approval.
VERIFIEDMint Markets·32d★ ON YOUR LIST
Top stocks in focus on Monday: Why investors watch RVNL, Mazagon Dock, Tata Motors shares - Know news, triggersAI summary· NEUTRAL
- ·Rail Vikas Nigam (RVNL) is among the stocks likely to remain in focus.
- ·Lupin is among the stocks likely to remain in focus.
- ·Tata Motors is among the stocks likely to remain in focus.
VERIFIEDET Stocks·42d★ ON YOUR LIST
Lupin share falls 2%; Citi downgrades to Sell, cuts target price to Rs 2,050AI summary· NEGATIVE
- ·Lupin shares declined by 2% following a downgrade by Citi.
- ·Citi reduced its target price for Lupin to Rs 2,050.
- ·The brokerage cited expectations of weaker US sales, margin pressure, and limited new product benefits.
VERIFIEDET Finance·49d★ ON YOUR LIST
Lupin arm to commercialise YUVEZZI eye drop across key European marketsAI summary· NEUTRAL
- ·Lupin's VISUfarma BV has obtained exclusive rights for the YUVEZZI eye drop in major European markets.
- ·YUVEZZI is an ophthalmic product designed to treat loss of clear close-up vision in adults.
- ·VISUfarma will manage regulatory processes and the commercial launch of the eye drop.
VERIFIEDET Stocks·51d★ ON YOUR LIST
Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepinessAI summary· NEUTRAL
- ·Lupin received USFDA approval for generic Pitolisant Tablets.
- ·The approval strengthens Lupin's US portfolio and specialty generics presence.
- ·The stock trades below most key moving averages, indicating subdued near-term momentum.
VERIFIEDET Finance·52d★ ON YOUR LIST
Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepinessAI summary· POSITIVE
- ·Lupin Ltd has received final USFDA approval for its generic Pitolisant tablets.
- ·The tablets are indicated for treating excessive daytime sleepiness.
- ·The USFDA approved strengths of 4.45 mg and 17.8 mg for the generic tablets.
VERIFIEDET Stocks·62d★ ON YOUR LIST
Lupin Q1 PAT rises 16 pc at Rs 1,417 crAI summary· POSITIVE
- ·Lupin Ltd reported a 16% surge in profit after tax for the first quarter.
- ·Consolidated total revenue from operations saw considerable growth.
- ·Sales in the US market increased by 42%, and India sales rose by nearly 14%.
VERIFIEDET Finance·69d★ ON YOUR LIST
Lupin launches generic Sugammadex injection in USAI summary· NEUTRAL
- ·Lupin Limited has launched its Sugammadex Injection in the United States.
- ·The launch follows approval from the US Food and Drug Administration.
- ·The injection is indicated for reversing neuromuscular blockade in surgical patients.
VERIFIEDMint Markets·78d★ ON YOUR LIST
Top Gainers & Losers on 22 July: Bandhan Bank, PG Electroplast, Lupin, Delhivery, Voltas, IndiGo among top losersAI summary· NEGATIVE
- ·The Indian stock market experienced a sell-off on July 22, with the Nifty 50 closing 0.77% lower.
- ·Middle East tensions and concerns over US tariffs on pharmaceuticals contributed to the market decline.
- ·Broader markets fell over 1%, with Nifty Media and Nifty Pharma sectors seeing significant drops.
Google News, NIFTY/SENSEX·78d★ ON YOUR LIST
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline - BusinessLineGoogle News, NIFTY/SENSEX·78d★ ON YOUR LIST
Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan - NDTV ProfitVERIFIEDMint Markets·78d★ ON YOUR LIST
Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines importAI summary· NEGATIVE
- ·Several Indian pharmaceutical companies experienced a decline in their stock prices.
- ·Aurobindo Pharma, Ajanta Pharma, Lupin, Gland Pharma, and Zydus Lifesciences were among the top decliners.
- ·The decline occurred following a plan by Donald Trump regarding tariffs on generic medicine imports.
VERIFIEDET Stocks·84d★ ON YOUR LIST
BHEL among 6 midcap stocks that hit 52-week highs and rallied up to 20% in a monthAI summary· POSITIVE
- ·Six BSE 150 MidCap stocks, including BHEL, reached new 52-week highs.
- ·These stocks experienced rallies of up to 20% within the last month.
- ·The performance indicates strong buying interest and sustained bullish momentum in the midcap segment.
VERIFIEDET Markets·84d★ ON YOUR LIST
BHEL among 6 midcap stocks that hit 52-week highs and rallied up to 20% in a monthAI summary· POSITIVE
- ·Six BSE 150 MidCap stocks, including BHEL, reached new 52-week highs.
- ·These stocks experienced rallies of up to 20% within the last month.
- ·The upward movement indicates strong buying interest and sustained bullish momentum.
VERIFIEDET Stocks·94d★ ON YOUR LIST
IndusInd Bank among 6 stocks to hit 52-week highs & rally up to 25% in a monthAI summary· POSITIVE
- ·Six BSE 100 stocks, including IndusInd Bank, Cholamandalam Investment, and Lupin, reached new 52-week highs.
- ·The Sensex increased by 521 points.
- ·This performance indicates strong buying interest and positive market momentum.
VERIFIEDMint Markets·97d★ ON YOUR LIST
Top Gainers & Losers on 3 July: Zensar Tech, HFCL, IndusInd Bank, Muthoot Finance, Lupin among top gainersAI summary· POSITIVE
- ·The Nifty 50 closed up 0.40% and the Sensex gained 0.35% on July 3.
- ·Realty sector led gains, while PSU Banks, Auto, and Metal sectors fell.
- ·Technology stocks showed signs of recovery amid easing rate hike concerns.
Google News, India stocks·99d★ ON YOUR LIST
Stocks to Watch Today: Lupin, CSM Technologies, Sai Parenterals, Bharti Airtel, V-Mart, Indian Bank,... - Moneycontrol.comVERIFIEDET Finance·104d★ ON YOUR LIST
Lupin gets USFDA tentative approval for prostate cancer treatment drugAI summary· POSITIVE
- ·Lupin Ltd has received tentative approval from the US FDA for its generic enzalutamide tablets.
- ·The drug is used for the treatment of advanced prostate cancer.
- ·The approval covers multiple strengths: 40 mg, 80 mg, 120 mg, and 160 mg.
VERIFIEDMint Markets·117d★ ON YOUR LIST
Stocks to buy: 3 stocks to beat the market in 2026: YES Securities lists Entero, Maruti and Lupin as June stock picksAI summary· POSITIVE
- ·YES Securities has identified Entero Healthcare, Maruti Suzuki, and Lupin as their top stock picks for June 2026.
- ·These selections are based on strong sector dynamics, improving financial performance, and positive growth outlooks.
- ·Potential price increases of 20% to 21% are anticipated for these stocks.
VERIFIEDMint Markets·136d★ ON YOUR LIST
Stocks to watch today: Hindalco, TVS Motor, Eicher Motors, NTPC, among stocks in focus on 25 May 2026AI summary· NEUTRAL
- ·Hindalco, TVS Motor, Eicher Motors, and NTPC are among the stocks to watch today.
- ·Lupin, Aurobindo Pharma, and Torrent Pharmaceuticals are also in focus.
- ·Colgate-Palmolive (India), Camlin Fine Sciences, Groww, and Tata Capital are other stocks in focus.
Google News, India stocks·143d★ ON YOUR LIST
Stocks to watch: BEL, IOC, Lupin among 10 shares in focus today; check list here - MintVERIFIEDMint Markets·143d★ ON YOUR LIST
Stocks to watch: BEL, IOC, Lupin among 10 shares in focus today; check list hereAI summary· POSITIVE
- ·BEL, IOC, and Lupin are among 10 shares in focus today.
- ·The Indian stock market is expected to continue its gaining streak.
- ·Gift Nifty trends indicate a positive opening on Tuesday.